Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health. The winner for 2022 is internationally known for his research on the human gut microbiome and its impact on health and disease.
The company honored him in 2013 with a Dr. Paul Janssen Award for Biomedical Research; now he's a Nobel Laureate. Learn about the transformational research that's led to these well-deserved scientific accolades.
Learn how their revolutionary work has not only had a crucial impact on the COVID-19 pandemic but is also paving the way for potential future vaccines and treatments.
Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., were just honored with the prestigious award for their work with gene-editing technology CRISPR. But they also have a connection to Johnson & Johnson—they were awarded the Dr. Paul Janssen Award in 2014. Learn more about what makes them so impressive.
Cancer. Diabetes. Autoimmune diseases. They're the common illnesses we have a better chance at fighting, thanks to Dr. Cantley's pioneering work. Learn more about his "magic molecule" research.
Learn about the revolutionary work they're both doing in the field of neurodegenerative disease that could prove important in fighting often-fatal conditions.
We sat down with the winner of the 2018 Dr. Paul Janssen Award for Biomedical Research to learn how his tireless cancer research efforts have helped revolutionize the way we treat the disease—and save lives.
Each year, Johnson & Johnson recognizes a scientist whose work has the potential to transform human health. We caught up with this year's winner, who has dedicated his career to studying the powers of mitochondrial DNA.